{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:10:27Z","timestamp":1762542627307,"version":"3.41.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","liver.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.cld.2016.12.006","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T22:15:19Z","timestamp":1486073719000},"page":"321-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["De Novo and Recurrence of Nonalcoholic Steatohepatitis After Liver Transplantation"],"prefix":"10.1016","volume":"21","author":[{"given":"Matthew","family":"Kappus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manal","family":"Abdelmalek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.cld.2016.12.006_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.cgh.2012.03.011","article-title":"Features, diagnosis, and treatment of nonalcoholic fatty liver disease","volume":"10","author":"Torres","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2016.12.006_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2007.02.009","article-title":"Epidemiology and natural history of NAFLD and NASH","volume":"11","author":"Ong","year":"2007","journal-title":"Clin Liver Dis"},{"issue":"1 Suppl","key":"10.1016\/j.cld.2016.12.006_bib3","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jhep.2015.02.041","article-title":"Current efforts and trends in the treatment of NASH","volume":"62","author":"Ratziu","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2016.12.006_bib4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.cld.2016.12.006_bib5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2015.07.019","article-title":"Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease","volume":"14","author":"Mittal","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2016.12.006_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/jgh.12212","article-title":"Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches","volume":"28","author":"Schuppan","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.cld.2016.12.006_bib7","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","article-title":"Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review","volume":"10","author":"White","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2016.12.006_bib8","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/hep.24268","article-title":"Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality","volume":"53","author":"Younossi","year":"2011","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2016.12.006_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but No other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2016.12.006_bib10","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/hep.510300604","article-title":"Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis","volume":"30","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2016.12.006_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1381\/0960892053576820","article-title":"Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients","volume":"15","author":"Ong","year":"2005","journal-title":"Obes Surg"},{"issue":"3","key":"10.1016\/j.cld.2016.12.006_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MOT.0b013e3283615d30","article-title":"Evolving aspects of liver transplantation for nonalcoholic steatohepatitis","volume":"18","author":"Charlton","year":"2013","journal-title":"Curr Opin Organ Transplant"},{"issue":"3","key":"10.1016\/j.cld.2016.12.006_bib13","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.transproceed.2012.10.009","article-title":"Recurrence of disease after liver transplantation","volume":"45","author":"Friman","year":"2013","journal-title":"Transplant Proc"},{"issue":"9","key":"10.1016\/j.cld.2016.12.006_bib14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1053\/jlts.2001.24644","article-title":"Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease","volume":"7","author":"Ong","year":"2001","journal-title":"Liver Transpl"},{"issue":"12","key":"10.1016\/j.cld.2016.12.006_bib15","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/lt.21943","article-title":"Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis","volume":"15","author":"Malik","year":"2009","journal-title":"Liver Transpl"},{"issue":"9","key":"10.1016\/j.cld.2016.12.006_bib16","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/00007890-199611150-00011","article-title":"Use of fatty donor liver is associated with diminished early patient and graft survival","volume":"62","author":"Marsman","year":"1996","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.cld.2016.12.006_bib17","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/jmri.22514","article-title":"T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis","volume":"33","author":"Hines","year":"2011","journal-title":"J\u00a0Magn Reson Imaging"},{"issue":"9","key":"10.1016\/j.cld.2016.12.006_bib18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.20452\/pamw.1919","article-title":"Relationship between ultrasound features of nonalcoholic fatty liver disease and cardiometabolic risk factors in patients with newly diagnosed type 2 diabetes","volume":"123","author":"Kosmalski","year":"2013","journal-title":"Pol Arch Med Wewn"},{"issue":"2","key":"10.1016\/j.cld.2016.12.006_bib19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/lt.24335","article-title":"Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors","volume":"22","author":"Wong","year":"2016","journal-title":"Liver Transpl"},{"issue":"10","key":"10.1016\/j.cld.2016.12.006_bib20","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1111\/hepr.12200","article-title":"Living donor liver transplantation for non-alcoholic steatohepatitis: a single center experience","volume":"44","author":"Tanaka","year":"2014","journal-title":"Hepatol Res"},{"issue":"11","key":"10.1016\/j.cld.2016.12.006_bib21","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0025-6196(11)60667-8","article-title":"Outcomes after liver transplant in patients aged 70 years or older compared with those younger than 60 years","volume":"84","author":"Aduen","year":"2009","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.cld.2016.12.006_bib22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1386-6346(02)00246-2","article-title":"Nonalcoholic steatohepatitis: risk factors for liver fibrosis","volume":"24","author":"Shimada","year":"2002","journal-title":"Hepatol Res"},{"issue":"10","key":"10.1016\/j.cld.2016.12.006_bib23","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/01.TP.0000436723.59879.01","article-title":"Nonalcoholic fatty liver disease epidemic and its implications for liver transplantation","volume":"96","author":"Kemmer","year":"2013","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.cld.2016.12.006_bib24","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/00007890-200009150-00012","article-title":"Long-term results of liver transplantation in older patients 60 years of age and older","volume":"70","author":"Collins","year":"2000","journal-title":"Transplantation"},{"issue":"1 Pt 2","key":"10.1016\/j.cld.2016.12.006_bib25","first-page":"1075","article-title":"Liver transplantation in patients beyond age 60","volume":"25","author":"Emre","year":"1993","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.cld.2016.12.006_bib26","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.cld.2016.12.006_bib27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1471-2458-7-220","article-title":"Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education program: the Norwegian HUNT 2 study","volume":"7","author":"Hildrum","year":"2007","journal-title":"BMC Public Health"},{"issue":"11","key":"10.1016\/j.cld.2016.12.006_bib28","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.2337\/dc06-0282","article-title":"Metabolic syndrome: prevalence and prediction of mortality in elderly individuals","volume":"29","author":"Ravaglia","year":"2006","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.cld.2016.12.006_bib29","first-page":"263","article-title":"Prevalence of metabolic syndrome in elderly and agreement among four diagnostic criteria","volume":"102","author":"Saad","year":"2014","journal-title":"Arq Bras Cardiol"},{"issue":"1","key":"10.1016\/j.cld.2016.12.006_bib30","first-page":"105","article-title":"Comparative analyses of genetic risk prediction methods reveal extreme diversity of genetic predisposition to nonalcoholic fatty liver disease (NAFLD) among ethnic populations of India","volume":"94","author":"Chatterjee","year":"2015","journal-title":"J\u00a0Genet"},{"issue":"2","key":"10.1016\/j.cld.2016.12.006_bib31","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/hep.20554","article-title":"Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease","volume":"41","author":"Weston","year":"2005","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2016.12.006_bib32","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/MPG.0b013e31819f73b4","article-title":"Ethnic and sex differences in the association between metabolic syndrome and suspected nonalcoholic fatty liver disease in a nationally representative sample of US adolescents","volume":"49","author":"Graham","year":"2009","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"6","key":"10.1016\/j.cld.2016.12.006_bib33","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cld.2016.12.006_bib34","first-page":"1613","article-title":"Frequency of nonalcoholic fatty liver disease and degree of hepatic steatosis in African-American patients","volume":"98","author":"Giday","year":"2006","journal-title":"J\u00a0Natl Med Assoc"},{"issue":"1","key":"10.1016\/j.cld.2016.12.006_bib35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.soard.2004.12.006","article-title":"Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients","volume":"1","author":"Solga","year":"2005","journal-title":"Surg Obes Relat Dis"},{"issue":"9403","key":"10.1016\/j.cld.2016.12.006_bib36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"WHO Expert Consultation","year":"2004","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.cld.2016.12.006_bib37","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/sj.ijo.0800741","article-title":"Body mass index and percent body fat: a meta-analysis among different ethnic groups","volume":"22","author":"Deurenberg","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"12","key":"10.1016\/j.cld.2016.12.006_bib38","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/oby.2002.169","article-title":"Abdominal obesity and ethnic differences in diabetes awareness, treatment, and glycemic control","volume":"10","author":"Okosun","year":"2002","journal-title":"Obes Res"},{"issue":"1","key":"10.1016\/j.cld.2016.12.006_bib39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/gast.2003.50004","article-title":"Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States","volume":"124","author":"Ruhl","year":"2003","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2016.12.006_bib40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MD.0b013e3182779d49","article-title":"Nonalcoholic fatty liver disease in lean individuals in the United States","volume":"91","author":"Younossi","year":"2012","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.cld.2016.12.006_bib41","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/hep.23784","article-title":"Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2016.12.006_bib42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.5500\/wjt.v4.i4.229","article-title":"Female gender in the setting of liver transplantation","volume":"4","author":"Rodriguez-Castro","year":"2014","journal-title":"World J Transplant"},{"issue":"12","key":"10.1016\/j.cld.2016.12.006_bib43","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.cgh.2010.08.005","article-title":"Regional anthropometric measures and hepatic fibrosis in patients with nonalcoholic Fatty liver disease","volume":"8","author":"Suzuki","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2016.12.006_bib44","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/hep.26761","article-title":"Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2016.12.006_bib45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cgh.2016.07.034","article-title":"Patient sex, reproductive status, and synthetic hormone use associate with histologic severity of nonalcoholic steatohepatitis","volume":"15","author":"Yang","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2016.12.006_bib46","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/hep.22726","article-title":"Ethnic differences in hepatic steatosis: an insulin resistance paradox?","volume":"49","author":"Guerrero","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2016.12.006_bib47","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1053\/j.gastro.2009.01.050","article-title":"Heritability of nonalcoholic fatty liver disease","volume":"136","author":"Schwimmer","year":"2009","journal-title":"Gastroenterology"},{"issue":"41","key":"10.1016\/j.cld.2016.12.006_bib48","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.3748\/wjg.v19.i41.6969","article-title":"PNPLA3 I148M polymorphism and progressive liver disease","volume":"19","author":"Dongiovanni","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.cld.2016.12.006_bib49","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.cld.2016.12.006_bib50","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1111\/liv.12318","article-title":"Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease","volume":"34","author":"Zelber-Sagi","year":"2014","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.cld.2016.12.006_bib51","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.18295\/squmj.2016.16.02.002","article-title":"Mechanisms of diabetes-induced liver damage: the role of oxidative stress and inflammation","volume":"16","author":"Mohamed","year":"2016","journal-title":"Sultan Qaboos Univ Med J"},{"issue":"2","key":"10.1016\/j.cld.2016.12.006_bib52","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/gut.2009.190801","article-title":"Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease","volume":"59","author":"Dongiovanni","year":"2010","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.cld.2016.12.006_bib53","doi-asserted-by":"crossref","first-page":"e48804","DOI":"10.1371\/journal.pone.0048804","article-title":"The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease","volume":"7","author":"Valenti","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.cld.2016.12.006_bib54","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.cgh.2013.06.025","article-title":"Patatin-like phospholipase domain-containing protein 3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosis","volume":"11","author":"Finkenstedt","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"34","key":"10.1016\/j.cld.2016.12.006_bib55","doi-asserted-by":"crossref","first-page":"10054","DOI":"10.3748\/wjg.v21.i34.10054","article-title":"PNPLA3 I148M variant affects non-alcoholic fatty liver disease in liver transplant recipients","volume":"21","author":"Liu","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2016.12.006_bib56","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0022-3476(95)70103-6","article-title":"Treatment and liver transplantation for cholesterol ester storage disease","volume":"127","author":"Leone","year":"1995","journal-title":"J\u00a0Pediatr"},{"issue":"7","key":"10.1016\/j.cld.2016.12.006_bib57","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1399-3046.2007.00767.x","article-title":"Recurrence of non-alcoholic steatohepatitis after liver transplantation in a 13-yr-old boy","volume":"11","author":"Jankowska","year":"2007","journal-title":"Pediatr Transplant"},{"issue":"2","key":"10.1016\/j.cld.2016.12.006_bib58","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/lt.500030212","article-title":"Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation","volume":"3","author":"Molloy","year":"1997","journal-title":"Liver Transpl Surg"},{"issue":"15\u201316","key":"10.1016\/j.cld.2016.12.006_bib59","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cca.2012.03.019","article-title":"A\u00a0new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2","volume":"413","author":"Hamilton","year":"2012","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.cld.2016.12.006_bib60","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jhep.2014.06.022","article-title":"Sebelipase alfa over 52\u00a0weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiency","volume":"61","author":"Valayannopoulos","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2016.12.006_bib61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/ajt.12581","article-title":"OPTN\/SRTR 2012 annual data report: liver","volume":"14","author":"Kim","year":"2014","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.cld.2016.12.006_bib62","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1600-6143.2007.02100.x","article-title":"The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database","volume":"8","author":"Leonard","year":"2008","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.cld.2016.12.006_bib63","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/00007890-199104000-00012","article-title":"Excessive weight gain after liver transplantation","volume":"51","author":"Palmer","year":"1991","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.cld.2016.12.006_bib64","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1432-2277.2004.00067.x","article-title":"Weight gain and obesity after liver transplantation","volume":"18","author":"Richards","year":"2005","journal-title":"Transpl Int"},{"issue":"3","key":"10.1016\/j.cld.2016.12.006_bib65","first-page":"45","article-title":"Risk factors and dynamics of weight gain in patients after liver transplantation","volume":"14","author":"Wawrzynowicz-Syczewska","year":"2009","journal-title":"Ann Transplant"},{"issue":"4","key":"10.1016\/j.cld.2016.12.006_bib66","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/lt.500040402","article-title":"Weight change and obesity after liver transplantation: incidence and risk factors","volume":"4","author":"Everhart","year":"1998","journal-title":"Liver Transpl Surg"},{"issue":"4","key":"10.1016\/j.cld.2016.12.006_bib67","first-page":"1351","article-title":"Overweight, obesity and weight gain up to three years after liver transplantation","volume":"27","author":"Rezende Anastacio","year":"2012","journal-title":"Nutr Hosp"},{"issue":"1","key":"10.1016\/j.cld.2016.12.006_bib68","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/TP.0b013e3181bcd682","article-title":"Cardiovascular risk profile of patients with acute liver failure after liver transplantation when compared with the general population","volume":"89","author":"Aberg","year":"2010","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.cld.2016.12.006_bib69","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/00365590802273226","article-title":"Determinants of short-term changes in body composition following renal transplantation","volume":"43","author":"Dolgos","year":"2009","journal-title":"Scand J Urol Nephrol"},{"issue":"5","key":"10.1016\/j.cld.2016.12.006_bib70","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1432-2277.2003.tb00304.x","article-title":"Weight changes after renal transplantation: a comparison between patients on 5-mg maintenance steroid therapy and those on steroid-free immunosuppressive therapy","volume":"16","author":"van den Ham","year":"2003","journal-title":"Transpl Int"},{"key":"10.1016\/j.cld.2016.12.006_bib71","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2046-4053-4-2","article-title":"Weight gain, overweight and obesity in solid organ transplantation\u2013a study protocol for a systematic literature review","volume":"4","author":"Beckmann","year":"2015","journal-title":"Syst Rev"},{"issue":"1","key":"10.1016\/j.cld.2016.12.006_bib72","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.soard.2014.06.015","article-title":"Liver disease in the morbidly obese: a review of 1000 consecutive patients undergoing weight loss surgery","volume":"11","author":"Subichin","year":"2015","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.cld.2016.12.006_bib73","first-page":"205","article-title":"Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus","volume":"57","author":"Prashanth","year":"2009","journal-title":"J\u00a0Assoc Physicians India"},{"issue":"3","key":"10.1016\/j.cld.2016.12.006_bib74","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","author":"Wong","year":"2015","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.cld.2016.12.006_bib75","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/lt.21952","article-title":"Posttransplant metabolic syndrome: an epidemic waiting to happen","volume":"15","author":"Pagadala","year":"2009","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2016.12.006_bib76","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1432-2277.2012.01576.x","article-title":"Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantation","volume":"26","author":"Sprinzl","year":"2013","journal-title":"Transpl Int"},{"issue":"8","key":"10.1016\/j.cld.2016.12.006_bib77","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/lt.21126","article-title":"Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events","volume":"13","author":"Laryea","year":"2007","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.cld.2016.12.006_bib78","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1432-2277.2007.00596.x","article-title":"Long-term results after liver transplantation","volume":"21","author":"Pfitzmann","year":"2008","journal-title":"Transpl Int"},{"issue":"4","key":"10.1016\/j.cld.2016.12.006_bib79","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/lt.500030409","article-title":"Hyperlipidemia in liver transplant recipients: prevalence and risk factors","volume":"3","author":"Gisbert","year":"1997","journal-title":"Liver Transpl Surg"},{"issue":"1","key":"10.1016\/j.cld.2016.12.006_bib80","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.TP.0000100685.70064.90","article-title":"Is there disparity between risk and incidence of cardiovascular disease after liver transplant?","volume":"77","author":"Neal","year":"2004","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.cld.2016.12.006_bib81","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhep.2010.01.040","article-title":"Metabolic syndrome and liver transplantation: a review and guide to management","volume":"53","author":"Watt","year":"2010","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2016.12.006_bib82","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ajg.2009.717","article-title":"Non-alcoholic fatty liver disease in liver transplant recipients: another story of \u201cseed and soil.\u201d","volume":"105","author":"Dumortier","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2016.12.006_bib83","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1530\/eje.0.1490543","article-title":"Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography","volume":"149","author":"Rockall","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.cld.2016.12.006_bib84","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/hep.24509","article-title":"Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice","volume":"54","author":"Mueller","year":"2011","journal-title":"Hepatology"},{"issue":"Pt 3","key":"10.1016\/j.cld.2016.12.006_bib85","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1042\/bj20031320","article-title":"Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone","volume":"378","author":"Dolinsky","year":"2004","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.cld.2016.12.006_bib86","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2045-3701-2-19","article-title":"Regulation of triglyceride metabolism by glucocorticoid receptor","volume":"2","author":"Wang","year":"2012","journal-title":"Cell Biosci"},{"key":"10.1016\/j.cld.2016.12.006_bib87","first-page":"29","article-title":"UNOS Liver Registry: ten year survivals","author":"Waki","year":"2006","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1016\/j.cld.2016.12.006_bib88","first-page":"108","article-title":"Immunosuppressive agents in organ transplantation: past, present, and future","volume":"20","author":"Hong","year":"2000","journal-title":"Semin Nephrol"},{"issue":"4","key":"10.1016\/j.cld.2016.12.006_bib89","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1177\/039463201002300440","article-title":"Long-term assessment of plasma lipids in transplant recipients treated with tacrolimus in relation to fatty liver","volume":"23","author":"Tarantino","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"6","key":"10.1016\/j.cld.2016.12.006_bib90","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1742-7843.2007.00066.x","article-title":"Compared effect of immunosuppressive drugs cyclosporine A and rapamycin on cholesterol homeostasis key enzymes CYP27A1 and HMG-CoA reductase","volume":"100","author":"Gueguen","year":"2007","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"4","key":"10.1016\/j.cld.2016.12.006_bib91","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/ki.1991.266","article-title":"Decreased postheparin lipolytic activity in renal transplant recipients with cyclosporin A","volume":"40","author":"Derfler","year":"1991","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.cld.2016.12.006_bib92","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/lt.20926","article-title":"Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension","volume":"13","author":"Orlando","year":"2007","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.cld.2016.12.006_bib93","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.transproceed.2009.01.091","article-title":"Low-density lipoprotein oxidizability and the alteration of its fatty acid content in renal transplant recipients treated with cyclosporine\/tacrolimus","volume":"41","author":"Bakar","year":"2009","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.cld.2016.12.006_bib94","first-page":"43","article-title":"Tacrolimus versus cyclosporine for early steroid withdrawal after renal transplantation","volume":"25","author":"Sandrini","year":"2012","journal-title":"J\u00a0Nephrol"},{"issue":"3 Suppl","key":"10.1016\/j.cld.2016.12.006_bib95","doi-asserted-by":"crossref","first-page":"209S","DOI":"10.1016\/S0041-1345(03)00217-3","article-title":"Ten years of sirolimus therapy in orthotopic liver transplant recipients","volume":"35","author":"Neff","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cld.2016.12.006_bib96","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejim.2015.12.022","article-title":"Changes in lipid and carbohydrate metabolism under mTOR- and calcineurin-based immunosuppressive regimen in adult patients after liver transplantation","volume":"29","author":"Zimmermann","year":"2016","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1016\/j.cld.2016.12.006_bib97","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bcp.2014.01.020","article-title":"Molecular mechanisms underlying the effects of cyclosporin A and sirolimus on glucose and lipid metabolism in liver, skeletal muscle and adipose tissue in an in\u00a0vivo rat model","volume":"88","author":"Fuhrmann","year":"2014","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.cld.2016.12.006_bib98","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jhep.2013.04.013","article-title":"Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial","volume":"59","author":"Wong","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2016.12.006_bib99","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/hep.28392","article-title":"Diet, weight loss, and liver health in nonalcoholic fatty liver disease: pathophysiology, evidence, and practice","volume":"63","author":"Marchesini","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2016.12.006_bib100","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2016.12.006_bib101","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/hep.23535","article-title":"Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease","volume":"51","author":"Abdelmalek","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2016.12.006_bib102","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/lt.24393","article-title":"Prevalence and risk factors of steatosis after liver transplantation and patient outcomes","volume":"22","author":"Hejlova","year":"2016","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2016.12.006_bib103","first-page":"115","article-title":"Active smoking, passive smoking, and risk of nonalcoholic fatty liver disease (NAFLD): a population-based study in China","volume":"23","author":"Liu","year":"2013","journal-title":"J\u00a0Epidemiol"},{"issue":"4","key":"10.1016\/j.cld.2016.12.006_bib104","doi-asserted-by":"crossref","first-page":"e96349","DOI":"10.1371\/journal.pone.0096349","article-title":"Risk of obstructive sleep apnea with daytime sleepiness is associated with liver damage in non-morbidly obese patients with nonalcoholic fatty liver disease","volume":"9","author":"Pulixi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cld.2016.12.006_bib105","doi-asserted-by":"crossref","first-page":"732870","DOI":"10.1155\/2015\/732870","article-title":"Treatment of nonalcoholic steatohepatitis in adults: present and future","volume":"2015","author":"Gitto","year":"2015","journal-title":"Gastroenterol Res Pract"},{"issue":"8","key":"10.1016\/j.cld.2016.12.006_bib106","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.metabol.2015.09.004","article-title":"The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome","volume":"65","author":"Aguilar-Olivos","year":"2016","journal-title":"Metabolism"},{"issue":"12","key":"10.1016\/j.cld.2016.12.006_bib107","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1007\/s11695-015-1691-x","article-title":"Bariatric surgery and non-alcoholic fatty liver disease: a systematic review of liver biochemistry and histology","volume":"25","author":"Bower","year":"2015","journal-title":"Obes Surg"},{"issue":"18","key":"10.1016\/j.cld.2016.12.006_bib108","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"10019","key":"10.1016\/j.cld.2016.12.006_bib109","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.cld.2016.12.006_bib110","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.3748\/wjg.v21.i25.7860","article-title":"Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome","volume":"21","author":"Kargiotis","year":"2015","journal-title":"World J Gastroenterol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326116301143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326116301143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T23:27:27Z","timestamp":1749943647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326116301143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":110,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1089326116301143"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2016.12.006","relation":{},"ISSN":["1089-3261"],"issn-type":[{"type":"print","value":"1089-3261"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"De Novo and Recurrence of Nonalcoholic Steatohepatitis After Liver Transplantation","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2016.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}